tirzepatide another name FDA approves new version of diabetes drug Mounjaro to be sold for weight loss Mounjaro (Tirzepatide) Injection for Weight
Description
Originally developed to manage type 2 diabetes, this GLP-1 receptor agonist has shown exceptional promise in tackling the global obesity epidemic
Third : incorporate fibre to promote satiety and digestive comfort
Semaglutide shares 94% sequence homology with human GLP-1
At its core, the platform operates as both a SaaS tool for healthcare providers and a patient-facing telehealth service
